CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 225,842 Value ($000) $10,513 Avg Close $44.52 Range $38.81 - $50.98

Q3 2025

Shares 217,690 Value ($000) $9,067 Avg Close $31.97 Range $25.83 - $47.41

Q2 2025

Shares 334,796 Value ($000) $9,629 Avg Close $30.88 Range $24.10 - $34.68

Q1 2025

Shares 347,581 Value ($000) $11,658 Avg Close $37.35 Range $31.65 - $53.55

Q4 2024

Shares 325,276 Value ($000) $16,631 Avg Close $55.95 Range $49.48 - $62.53

Q3 2024

Shares 271,747 Value ($000) $13,886 Avg Close $51.57 Range $43.71 - $55.78

Q2 2024

Shares 260,980 Value ($000) $11,689 Avg Close $46.18 Range $41.01 - $53.70

Q1 2024

Shares 211,820 Value ($000) $9,915 Avg Close $39.13 Range $33.67 - $47.58

Q4 2023

Shares 63,175 Value ($000) $2,248 Avg Close $30.67 Range $25.35 - $37.88

Q3 2023

Shares 62,826 Value ($000) $1,868 Avg Close $20.61 Range $15.76 - $31.00

Q2 2023

Shares 13,745 Value ($000) $221 Avg Close $19.94 Range $15.50 - $24.58

Q1 2023

Shares 13,745 Value ($000) $221 Avg Close $18.51 Range $15.23 - $21.65

Q4 2022

Shares 26,066 Value ($000) $477 Avg Close $17.62 Range $15.37 - $19.97

Q3 2022

Shares 26,066 Value ($000) $511,936 Avg Close $20.39 Range $17.79 - $22.85

Q2 2022

Shares 13,745 Value ($000) $256,344 Avg Close $19.96 Range $15.91 - $27.86

Q1 2022

Shares 15,021 Value ($000) $329,711 Avg Close $20.24 Range $16.53 - $28.95

Q4 2021

Shares 22,972 Value ($000) $652,634 Avg Close $24.65 Range $18.97 - $28.82

Q3 2021

Shares 16,140 Value ($000) $339,747 Avg Close $20.92 Range $16.68 - $25.50

Q2 2021

Shares 16,140 Value ($000) $304,239 Avg Close $17.57 Range $15.15 - $21.64

Q1 2021

Shares 14,503 Value ($000) $221,606 Avg Close $15.50 Range $13.29 - $18.09

Q4 2020

Shares 14,503 Value ($000) $204,637 Avg Close $13.93 Range $11.61 - $17.84

Q3 2020

Shares 10,503 Value ($000) $164,582 Avg Close $15.29 Range $13.12 - $18.12

Q2 2020

Shares 33,254 Value ($000) $582,610 Avg Close $17.05 Range $12.50 - $23.70

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	225,842	$10,513	$44.52	$38.81 - $50.98
Q3 2025	217,690	$9,067	$31.97	$25.83 - $47.41
Q2 2025	334,796	$9,629	$30.88	$24.10 - $34.68
Q1 2025	347,581	$11,658	$37.35	$31.65 - $53.55
Q4 2024	325,276	$16,631	$55.95	$49.48 - $62.53
Q3 2024	271,747	$13,886	$51.57	$43.71 - $55.78
Q2 2024	260,980	$11,689	$46.18	$41.01 - $53.70
Q1 2024	211,820	$9,915	$39.13	$33.67 - $47.58
Q4 2023	63,175	$2,248	$30.67	$25.35 - $37.88
Q3 2023	62,826	$1,868	$20.61	$15.76 - $31.00
Q2 2023	13,745	$221	$19.94	$15.50 - $24.58
Q1 2023	13,745	$221	$18.51	$15.23 - $21.65
Q4 2022	26,066	$477	$17.62	$15.37 - $19.97
Q3 2022	26,066	$511,936	$20.39	$17.79 - $22.85
Q2 2022	13,745	$256,344	$19.96	$15.91 - $27.86
Q1 2022	15,021	$329,711	$20.24	$16.53 - $28.95
Q4 2021	22,972	$652,634	$24.65	$18.97 - $28.82
Q3 2021	16,140	$339,747	$20.92	$16.68 - $25.50
Q2 2021	16,140	$304,239	$17.57	$15.15 - $21.64
Q1 2021	14,503	$221,606	$15.50	$13.29 - $18.09
Q4 2020	14,503	$204,637	$13.93	$11.61 - $17.84
Q3 2020	10,503	$164,582	$15.29	$13.12 - $18.12
Q2 2020	33,254	$582,610	$17.05	$12.50 - $23.70